2009
DOI: 10.1007/s00431-009-0955-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical practice. Diagnosis and treatment of cow’s milk allergy

Abstract: Introduction Cow’s milk allergy (CMA) is thought to affect 2–3% of infants. The signs and symptoms are nonspecific and may be difficult to objectify, and as the diagnosis requires cow’s milk elimination followed by challenge, often, children are considered cow’s milk allergic without proven diagnosis. Diagnosis Because of the consequences, a correct diagnosis of CMA is pivotal. Open challenges tend to overestimate the number of children with CMA. The only reliable way t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0
16

Year Published

2010
2010
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(47 citation statements)
references
References 39 publications
0
30
0
16
Order By: Relevance
“…However, the incidence is significantly less in infants who are exclusively breastfed, at a rate of about 0.5% to 1% (Helm, 2014). The fact that cow's milk proteins (CMP) constitute the first food antigens to be introduced into the infant diet may partly explain this food allergy being the most frequent and precocious (Vandenplas et al, 2007;Kneepkens & Meijer, 2009;Drsi et al, 2009). The clinical presentation is generally moderate in infants, which can be explained by CMP concentration in breast milk (BM) being 100,000 times less than the concentration found in infant formulas (Table 1).…”
Section: Overviewmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the incidence is significantly less in infants who are exclusively breastfed, at a rate of about 0.5% to 1% (Helm, 2014). The fact that cow's milk proteins (CMP) constitute the first food antigens to be introduced into the infant diet may partly explain this food allergy being the most frequent and precocious (Vandenplas et al, 2007;Kneepkens & Meijer, 2009;Drsi et al, 2009). The clinical presentation is generally moderate in infants, which can be explained by CMP concentration in breast milk (BM) being 100,000 times less than the concentration found in infant formulas (Table 1).…”
Section: Overviewmentioning
confidence: 99%
“…Also, environmental factors such as neonatal antecedents that alter the formation of intestinal flora, as well as prematurity, antibiotic therapy early in life, or early and sporadic contact with CMP in utero through breast milk or through occasional formula administration to infants seem to cause CMPA predisposition. Exclusive breastfeeding for four to six months appears to be a protective factor, for not only CMPA but also other food allergies (Vandenplas et al, 2007;Kneepkens & Meijer, 2009). …”
Section: Overviewmentioning
confidence: 99%
“…İlk bir yaşta açık kontrollü besin yükleme testi, 1-2 yaş-tan büyük çocuklarda ise çift kör plasebo kontrollü besin yükleme testi önerilir. Deri testleri ve spesifik IgE testi negatif olsa bile öykü kuvvetli ise yükleme testi yine de yapılmalıdır [1,[19][20][21]. Ancak anafilaksi öyküsü varsa yükleme testi kontrendikedir.…”
Section: Besin Yükleme Testleriunclassified
“…Como regra geral, os anti-histamínicos devem ser suspensos, mas não há consenso de quanto tempo antes do TPO o paciente deve evitar esse medicamento. Entre os trabalhos publicados, a recomendação varia de três a dez dias (9,11,12,24,(32)(33)(34) . Corticosteroides inalatórios podem ser mantidos em doses mínimas suficientes para controlar a asma, e os corticosteroides tópicos podem ser aplicados em pequenas áreas da pele (11,12,24) .…”
Section: Orientações Pré-testeunclassified